LEM Holding SA

LEHN.SW·Swiss·Technology
Compare
589.00+5.00 (+0.86%)today
As of Nov 5, 12:04 PM CET · May be delayed up to 15 min · CHF

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close584.00
Open581.00
Day range578.00597.00
52-week range254.50715.00
Off day high−1.34%
Off 52-week high−17.62%
Volume1.76K
Avg. volume (3M)2.51K
Market cap670.59M
EPS (TTM)8.63
Forward P/E19.08
P/E ratio (TTM)68.25
Dividend yield—
Beta (5Y)0.93
Shares outstanding1.14M
Short interest—
Earnings dateNov 10, 2026
Analyst target594.80
Profit margin5.71%

Against its peers

Compare in full ›
LEHN.SW RAL 0RB7.IL AWX.SI LET.F ALSEM.PA
Market cap 670.59M 7.92B 52.39B 2.04B 654.72M 405.21M
P/E (TTM) 68.3 — 61.8 45.5 25.8 34.2
Forward P/E 19.1 21.2 — 17.8 — 24.3
Price/book 5.0 4.9 14.9 3.8 1.9 17.3
Dividend yield — 0.28% 1.55% 0.46% 1.96% 1.10%
1-year change +35.03% +60.61% +5.87% +334.97% −23.68% +55.38%
Today +0.86% +0.38% +0.21% −19.97% +2.18% −1.75%

The closest companies by business and industry (Electronic Components). Prices may be delayed up to 15 min.

Latest news

All LEHN.SW news ›
@onclive·

FDA approves Lupin's generic amifampridine for LEMS

Contemporary Pediatrics connects pediatricians with peer-reviewed articles, guideline updates, and practice strategies for real-world clinical application. The FDA has approved Lupin's abbreviated new drug application (ANDA) for…

LLY
@AJMC_Journal·Negative

How Group Purchasing Organizations Affect Access to LEMS Therapy

Group purchasing organizations shape drug access for most community oncology practices, and amifampridine's unusual profile leaves open questions about how that relationship will function. This episode, "How Group Purchasing Organizations…

RunRepeat·Negative

Lems ZENSPEED+ review

In our opinion, the Lems ZENSPEED+ is an interesting option for: The biggest issue with the Lems ZENSPEED+ is its lack of energy return. If that really matters to you, the Altra Escalante 5 is a much better (and cheaper) alternative. We…

@AJMC_Journal·Positive

Making the Case for Earlier LEMS Screening to Payers

AJMC In "Making the Case for Earlier LEMS Screening to Payers," the panel closes the series with a hypothetical pitch to the managed care community Patel poses a hypothetical to close the conversation: if Dr Iams had the floor at a summit…

@AJMC_Journal·Positive

Ordering VGCC Testing and Navigating NCCN Guidelines for LEMS

Getting a voltage-gated calcium channel antibody test ordered correctly takes attention to detail, and NCCN's explicit recommendation is reshaping how quickly clinicians act on it. This episode, "Ordering VGCC Testing and Navigating NCCN…

From the 4Search news index, newest first.

In the news

1mentions in 30 days
1with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 1 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance